• About
  • Subscribe
  • Advertise
  • Contact
Friday, July 10, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Australian Private Hospitals Association: Private hospitals hold key to productivity gains

by Staff Writer
August 20, 2025
in Federal Government, Local, News, Ophthalmic insights, Policy & regulation
Reading Time: 5 mins read
A A
Both Health Minister Mark Butler and the ASO have called on health insurers to do better for their patients. Image: Rawpixel.com/Shutterstock.com.

Both Health Minister Mark Butler and the ASO have called on health insurers to do better for their patients. Image: Rawpixel.com/Shutterstock.com.

Share on FacebookShare on Twitter

The peak body for private hospitals – which perform 72% of the Australia’s eye surgeries – is worried about the sector’s viability and has called for expanded use of private facilities for public procedures, as a new Productivity Commission (PC) report suggests improvements to Australia’s ‘care economy’.

The Australian Private Hospitals Association (APHA) said the country’s public-private hospital blend had consistently ranked number one in the world – but that standing has “never been more precarious”.

It welcomed the release of the PC’s Interim Report Delivering quality care more efficiently, that it said recognised the vital role private hospitals play in Australia’s complementary hospital system. It also came as the nation prepares for the Treasurer’s three-day Economic Forum being held 19-21 August 2025.

“We remain positive about the role of private hospitals in Australian healthcare delivery, but we need federal and state governments to come with us,” APHA CEO Mr Brett Heffernan said. “And it doesn’t have to cost anything.

“Taxpayers get a massive return on zero investment in private hospitals. Just 633 private hospitals carry out 70% of planned surgery, 61% of acute mental healthcare, 81% of rehabilitation and 1.66 million medical treatments each year, including 54% of chemotherapy. They do so in high quality facilities with state-of-the-art treatments and services.”

Heffernan said that’s “an enormous chunk of the healthcare needs of Australians”. In fact, APHA said more than 5.14 million patients were admitted to private hospitals last year, up 3% on the year before.

But they could be doing much more “if the shackles of bureaucratic red-tape and insurer intransigence are removed”.

“Taxpayers are forking out around $400 billion for 675 public hospitals over the five-year life of the federal-state healthcare agreement. That figure is set to soar with the new agreement currently being negotiated,” Heffernan said.

“A more collaborative partnership between private and public hospitals, making the most of private facilities, capabilities and spare beds, needs to be a priority. It was relied upon by federal and state governments during COVID but has quickly been forgotten. That needs to change.”

He was pleased the PC report picked up on these issues. It suggests the Australian Government should empower Primary Health Networks with the flexibility to commission services aligned with local priorities, supported by dedicated funding streams.

“Governments are encouraged to shape the care economy by breaking down silos across sectors and making reforms that enhance inter-sector connectivity. This approach is essential for a resilient, sustainable healthcare system,” Heffernan said.

“APHA supports these reforms, emphasising the need for a healthcare model that leverages private hospital capacity to better address national challenges, such as elective surgery backlogs, chronic disease management, and hospital-in-the-home (HITH) services.

“Private hospitals already provide HITH services for public patients, but barriers prevent them from delivering these services to private patients. In particular, health insurers typically only fund HITH services that they themselves provide. An obstacle that must be addressed.”

He also noted private hospitals had provided high-quality care, expanded treatment options, and alleviated pressure on public hospitals. Their direct contribution to the economy exceeds $24 billion annually, supporting 155,000 direct jobs and many more across upstream and downstream industries.

“Yet, ongoing neglect and a lack of strategic support threaten the sector’s viability at a time when Australia needs it most. Importantly, private hospitals are not seeking taxpayer dollars, just a better deal from health insurance companies making record profits while refusing to meet health costs,” Heffernan said.

‘Health insurers need private hospitals to survive’

Earlier, on 25 June 2025, the peak body representing health insurers, Private Healthcare Australia, said health funds were delivering hundreds of millions of dollars in additional payments to private hospitals to help them through a challenging period of rising costs and a shift towards more technology driven out-of-hospital care.

Following a request from Health Minister Mr Mark Butler for health insurers to lift payments to private hospitals, the body said the most recent Australian Prudential Regulation Authority data shows health insurance payments to private hospitals jumped 7.7% in the year to March 2025. During the same period, health insurers paid private hospitals 4.2% more per episode of treatment.

This jump in payments to hospitals comes after health insurers paid more than $5 billion back to health fund members due to lower claims during the pandemic.

CEO of Private Healthcare Australia, Dr Rachel David, said health insurers were acting on Butler’s concerns about the private hospital sector by cutting their own costs and lifting payments to hospitals for the care they deliver.

“Health insurers need private hospitals to survive. We want our 12 million members investing in hospital cover to receive rapid access to high quality hospital treatment where and when they need it. With this in mind, we are paying hospitals more to help them meet rising costs for care, including higher staff wages,” Dr David said.

“The health insurance sector is listening and acting. We will continue to work with hospitals, doctors and the government on ways to improve our private health system and help modernise it so it can meet the needs of our population demanding more affordable, convenient and connected care.”

More reading

Healthscope private hospital group enters administration

Optometry Australia says health insurance rules a ‘minefield’

More reaction to scrapping of health insurance cover for macular injections

Related Posts

Dry eye symptoms are highly influential in diagnosis and treatment. Image: WavebreakMediaMicro.

CPD: TFOS DEWS III – DEW and improved

by staff writer
July 10, 2026

At the completion of this article, the reader should… •  Understand the key updates introduced in TFOS DEWS III. • ...

George & Matilda Eyecare boss Chris Beer has taken on a new role as executive chair of the network. Image: Prime Creative Media.

Chris Beer – not retiring, just changing lanes

by Rob Mitchell
July 10, 2026

Former CEO Chris Beer has a new role at George & Matilda Eyecare, but it’s not the end of his...

UNSW has achieved a top ranking. Image: UNSW.

UNSW named No. 1 in world for optometry research excellence

by Staff Writer
July 9, 2026

The UNSW School of Optometry & Vision Science has been recognised as the world's leading optometry school for research excellence,...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited